skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

27 Total results for product and free and sample content found

Datamonitor Healthcare

Datamonitor Healthcare Podcast 04 April 2018

By Jack Allen 09 Apr 2018

Zach McLellan & Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including analysis on Allogene's announcement that they are in-licensing the TALEN technology from Pfizer to commericalise and develop allogeneic, potentially leading to a strong acceleration of CART therapies.

Topic Drug development landscape

Datamonitor Healthcare

Datamonitor Healthcare Podcast 16 March 2018

By Jack Allen 20 Mar 2018

Zach McLellan, Jack Allen, and guest analysts Louisa Joseph and Michael Haydock discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including results for Gilead's new HIV flagship product; Biktarvy, and the US approval of the HIV drug Trogarzo, the first for salvage patients.

Topic Clinical trials Infectious diseases

Medtech Insight

Medtech Insights Device Week Podcast - Approvals And M&A

By David Filmore 12 Mar 2018

In this edition of Device Week, Medtech Insight’s Reed Miller, David Filmore and Catherine Longworth look back at the past year and the key trends in US and international product approvals, as well as in M&A activity. They also give their perspectives on what to look forward to in 2018.

Topic Medtech

Datamonitor Healthcare

Datamonitor Healthcare Podcast 02 March 2018

By Jack Allen 09 Mar 2018

Zach McLellan, Jack Allen, and guest analyst Dan Chancellor discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. Featuring analysis of the Sangamo Therapeutics and Gilead/Kite partnership for allogeneic oncology products & update on Restasis patent disputes.

Topic Company analysis

Datamonitor Healthcare

Datamonitor Healthcare Podcast 16 February 2018

By Zachary McLellan 19 Feb 2018

Zach McLellan and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including a recap of the 2018 BIO CEO conference, Phase IIb results of aramchol in HIV-lipodystrophy NAFLD or NASH patients, and the approval of Ereleada (apalutamide) in non-metastatic castration-resistant prostate cancer.

Topic Business strategies BioPharmaceutical

Datamonitor Healthcare

Datamonitor Healthcare Podcast 02 February 2018

By Jack Allen 09 Feb 2018

Zach McLellan, Jack Allen, and this weeks guest analyst from London, Ines Mihel, discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. This episode of the podcast features a discussion around the announcement of "profit-free" health insurance plans from Amazon, JP Morgan, and Berkshire Hathaway.

Topic Drug approval

Datamonitor Healthcare

Datamonitor Healthcare Podcast 19 January 2018

22 Jan 2018

Zach McLellan, Jack Allen, and this weeks guest analyst Dustin Phan, discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. This episode of the podcast features a discussion of Celgene's potential acquisition of Juno.

Topic Cancer Clinical trials

Datamonitor Healthcare

Datamonitor Healthcare Podcast 05 January 2018

07 Jan 2018

Zach McLellan and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. This episode of the podcast features a roundtable discussion of potential deals prior to the JPM Healthcare Conference.

Topic Cancer

Datamonitor Healthcare

Datamonitor Healthcare Podcast 20 December 2017

20 Dec 2017

Zach McLellan, Kevin Shannon and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast including Results from bluebird bio’s anti-BCMA CAR T.

Topic Cancer Clinical trials

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: